Stock A311390 NEO CREMAR CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Neo Cremar Co., Ltd.

Equities

A311390

KR7311390009

Food Processing

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
6,300 KRW +0.80% Intraday chart for Neo Cremar Co., Ltd. -0.47% -11.64%
Feb. 28 Neo Cremar Co., Ltd. announced that it expects to receive KRW 12.00000252 billion in funding from ASIA Holdings CO., Ltd., Asia Development Co., Ltd. CI
2023 Tranche Update on Neo Cremar Co., Ltd.'s Equity Buyback Plan announced on June 20, 2022. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 71,399 62,552 120,912 69,893 67,590
Enterprise Value (EV) 1 65,160 55,822 112,634 50,512 39,032
P/E ratio 60 x 45 x 66.8 x -32 x -11.4 x
Yield - - - - -
Capitalization / Revenue 3.61 x 2.1 x 4.05 x 2.62 x 2.72 x
EV / Revenue 3.29 x 1.87 x 3.77 x 1.89 x 1.57 x
EV / EBITDA 36 x 20.9 x 39.4 x 18 x 23.3 x
EV / FCF -6.04 x -325 x 109 x 837 x 6.6 x
FCF Yield -16.6% -0.31% 0.91% 0.12% 15.1%
Price to Book 1.89 x 1.58 x 2.91 x 1.23 x 1.74 x
Nbr of stocks (in thousands) 7,256 7,316 7,328 9,484 9,480
Reference price 2 9,840 8,550 16,500 7,370 7,130
Announcement Date 3/18/20 3/19/21 3/22/22 3/23/23 3/18/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 19,777 29,821 29,887 26,703 24,867
EBITDA 1 1,810 2,666 2,862 2,809 1,675
EBIT 1 665.1 1,259 1,369 1,420 278.9
Operating Margin 3.36% 4.22% 4.58% 5.32% 1.12%
Earnings before Tax (EBT) 1 1,016 1,368 1,755 -1,371 -5,294
Net income 1 1,025 1,385 1,837 -1,828 -4,958
Net margin 5.18% 4.65% 6.15% -6.84% -19.94%
EPS 2 164.0 190.0 247.0 -230.2 -623.2
Free Cash Flow 1 -10,788 -171.6 1,030 60.38 5,910
FCF margin -54.55% -0.58% 3.45% 0.23% 23.77%
FCF Conversion (EBITDA) - - 36.01% 2.15% 352.95%
FCF Conversion (Net income) - - 56.08% - -
Dividend per Share - - - - -
Announcement Date 3/18/20 3/19/21 3/22/22 3/23/23 3/18/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 6,240 6,730 8,278 19,382 28,558
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -10,788 -172 1,030 60.4 5,910
ROE (net income / shareholders' equity) 3.36% 3.52% 4.4% -3.27% -7.3%
ROA (Net income/ Total Assets) 1.05% 1.63% 1.7% 1.38% 0.23%
Assets 1 97,975 84,841 107,887 -132,388 -2,111,531
Book Value Per Share 2 5,197 5,422 5,674 6,000 4,091
Cash Flow per Share 2 878.0 945.0 1,170 711.0 1,061
Capex 1 6,824 1,325 405 387 299
Capex / Sales 34.5% 4.44% 1.35% 1.45% 1.2%
Announcement Date 3/18/20 3/19/21 3/22/22 3/23/23 3/18/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
NEO CREMAR CO., LTD. Stock Neo Cremar Co., Ltd.
-11.64% 49.48M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.21% 8.01B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
-0.47% 7.36B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+12.30% 6.54B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.99% 3.73B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-7.95% 3.42B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-4.78% 1.24B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+12.61% 935M
HERBALIFE LTD. Stock Herbalife Ltd.
-43.32% 886M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-22.54% 827M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. A311390 Stock
  4. Financials Neo Cremar Co., Ltd.